Tadd S. Wessel insider trades

Open-market stock purchases and sales by Tadd S. Wessel, Director at Palvella Therapeutics, Inc, from SEC Form 4 filings since Dec 13, 2024.

Recent trades

DateStockTradeValue
Jun 10, 2026PVLA Palvella Therapeutics, IncBought (not open market)—

Companies traded

  • PVLA Palvella Therapeutics, Inc: other filings, last Jun 10, 2026

Get free alerts when Tadd S. Wessel files a new trade →